CIMAP3
gene geneOn this page
Also known as FLJ23853pitchfork
Summary
CIMAP3 (ciliary microtubule associated protein 3, HGNC:27009) is a protein-coding gene on chromosome 1p13.2, encoding Ciliary microtubule-associated protein 3 (Q8TCI5). During primary cilia disassembly, involved in cilia disassembly.
Enables cytoskeletal protein binding activity and enzyme binding activity. Involved in positive regulation of kinase activity. Predicted to be located in ciliary basal body and trans-Golgi network.
Source: NCBI Gene 128344 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 31 total
- MANE Select transcript:
NM_181643
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27009 |
| Approved symbol | CIMAP3 |
| Name | ciliary microtubule associated protein 3 |
| Location | 1p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ23853, pitchfork |
| Ensembl gene | ENSG00000173947 |
| Ensembl biotype | protein_coding |
| OMIM | 614234 |
| Entrez | 128344 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000369737, ENST00000369738, ENST00000468395, ENST00000484512
RefSeq mRNA: 2 — MANE Select: NM_181643
NM_001300831, NM_181643
CCDS: CCDS72836, CCDS833
Canonical transcript exons
ENST00000369738 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001189011 | 111348516 | 111348646 |
| ENSE00001832812 | 111346622 | 111346671 |
| ENSE00003491520 | 111350106 | 111350223 |
| ENSE00003578356 | 111347674 | 111347772 |
| ENSE00003587786 | 111346910 | 111347049 |
| ENSE00003619429 | 111351259 | 111353013 |
Expression profiles
Bgee: expression breadth ubiquitous, 180 present calls, max score 99.60.
FANTOM5 (CAGE): breadth broad, TPM avg 6.8558 / max 340.4910, expressed in 903 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 4629 | 5.5577 | 718 |
| 4625 | 1.0155 | 414 |
| 4627 | 0.1098 | 52 |
| 4628 | 0.0973 | 25 |
| 4626 | 0.0384 | 12 |
| 4630 | 0.0371 | 18 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 99.60 | gold quality |
| right uterine tube | UBERON:0001302 | 99.35 | gold quality |
| bronchus | UBERON:0002185 | 99.03 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 97.90 | gold quality |
| oviduct epithelium | UBERON:0004804 | 97.37 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 96.64 | gold quality |
| sperm | CL:0000019 | 94.28 | gold quality |
| fallopian tube | UBERON:0003889 | 92.82 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 92.05 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 91.17 | gold quality |
| left testis | UBERON:0004533 | 91.09 | gold quality |
| right testis | UBERON:0004534 | 90.87 | gold quality |
| caput epididymis | UBERON:0004358 | 90.40 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.26 | gold quality |
| testis | UBERON:0000473 | 89.49 | gold quality |
| buccal mucosa cell | CL:0002336 | 88.04 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.78 | gold quality |
| trachea | UBERON:0003126 | 84.19 | gold quality |
| adenohypophysis | UBERON:0002196 | 83.59 | gold quality |
| right lung | UBERON:0002167 | 83.48 | gold quality |
| right atrium auricular region | UBERON:0006631 | 83.48 | gold quality |
| cardiac atrium | UBERON:0002081 | 83.26 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 83.06 | gold quality |
| apex of heart | UBERON:0002098 | 82.74 | gold quality |
| pituitary gland | UBERON:0000007 | 82.55 | gold quality |
| adult organism | UBERON:0007023 | 82.25 | gold quality |
| hypothalamus | UBERON:0001898 | 81.01 | gold quality |
| kidney epithelium | UBERON:0004819 | 80.48 | gold quality |
| caudate nucleus | UBERON:0001873 | 80.21 | gold quality |
| body of pancreas | UBERON:0001150 | 80.06 | gold quality |
Single-cell (SCXA)
Detected in 11 experiment(s), a significant marker in 11.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-15 | yes | 1949.64 |
| E-MTAB-9388 | yes | 1803.49 |
| E-CURD-114 | yes | 1341.91 |
| E-MTAB-10283 | yes | 1311.41 |
| E-MTAB-9154 | yes | 1139.81 |
| E-MTAB-10287 | yes | 1000.64 |
| E-MTAB-10485 | yes | 632.21 |
| E-MTAB-6108 | yes | 201.97 |
| E-HCAD-1 | yes | 32.53 |
| E-GEOD-130148 | yes | 16.03 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
48 targeting CIMAP3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-6759-5P | 99.99 | 66.54 | 785 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-202-3P | 99.84 | 71.41 | 1290 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-4694-3P | 99.79 | 69.53 | 2640 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-4428 | 99.73 | 66.41 | 1733 |
| HSA-MIR-7161-5P | 99.68 | 68.92 | 1592 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-3153 | 99.55 | 67.59 | 2337 |
| HSA-MIR-6832-3P | 99.52 | 70.44 | 1726 |
| HSA-MIR-4489 | 99.50 | 65.56 | 785 |
| HSA-MIR-513C-5P | 99.50 | 68.42 | 1730 |
| HSA-MIR-6727-3P | 99.49 | 65.92 | 1333 |
| HSA-MIR-6882-5P | 99.35 | 71.13 | 1206 |
| HSA-MIR-4477B | 99.23 | 70.49 | 1733 |
| HSA-MIR-4292 | 99.16 | 65.57 | 1767 |
| HSA-MIR-6791-5P | 99.16 | 65.92 | 1844 |
| HSA-MIR-323B-3P | 99.14 | 68.89 | 725 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-66i15.4 | ENSDARG00000097071 |
| mus_musculus | Cimap3 | ENSMUSG00000010136 |
| rattus_norvegicus | Cimap3 | ENSRNOG00000016842 |
Protein
Protein identifiers
Ciliary microtubule-associated protein 3 — Q8TCI5 (reviewed: Q8TCI5)
Alternative names: Protein pitchfork
All UniProt accessions (1): Q8TCI5
UniProt curated annotations — full annotation on UniProt →
Function. During primary cilia disassembly, involved in cilia disassembly. Required specifically to control cilia retraction as well as the liberation and duplication of the basal body/centrosome. May act by stimulating AURKA activity at the basal body in a cell cycle-dependent manner.
Subunit / interactions. Interacts with proteins involved in ciliary transport, including ARL13B, CETN1, KIF3A, RAB6A, RAB8A, TUBB1 and TUBG1. Interacts with AURKA.
Subcellular location. Cytoplasmic vesicle. Golgi apparatus. trans-Golgi network. Cytoplasm.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TCI5-1 | 1 | yes |
| Q8TCI5-2 | 2 | |
| Q8TCI5-3 | 3 |
RefSeq proteins (2): NP_001287760, NP_857594* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010736 | SHIPPO-rpt | Repeat |
| IPR033602 | CIMAP3 | Family |
Pfam: PF07004
UniProt features (8 total): sequence variant 3, splice variant 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TCI5-F1 | 72.99 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 79 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, GOBP_REGULATION_OF_PHOSPHORYLATION, GOBP_REGULATION_OF_TRANSFERASE_ACTIVITY, GOMF_GTPASE_BINDING, CHANDRAN_METASTASIS_DN, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, GOBP_EMBRYONIC_HEART_TUBE_DEVELOPMENT, GOCC_TRANS_GOLGI_NETWORK, GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_POSITIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS, GOBP_CILIUM_ORGANIZATION, GOBP_EMBRYO_DEVELOPMENT
GO Biological Process (5): regulation of cell projection organization (GO:0031344), positive regulation of kinase activity (GO:0033674), cilium organization (GO:0044782), embryonic heart tube left/right pattern formation (GO:0060971), cell projection organization (GO:0030030)
GO Molecular Function (7): cytoskeletal protein binding (GO:0008092), kinesin binding (GO:0019894), protein kinase binding (GO:0019901), small GTPase binding (GO:0031267), gamma-tubulin binding (GO:0043015), beta-tubulin binding (GO:0048487), protein binding (GO:0005515)
GO Cellular Component (6): nucleus (GO:0005634), trans-Golgi network (GO:0005802), cytoplasmic vesicle (GO:0031410), ciliary basal body (GO:0036064), cytoplasm (GO:0005737), Golgi apparatus (GO:0005794)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| tubulin binding | 2 |
| intracellular membrane-bounded organelle | 2 |
| cytoplasm | 2 |
| cell projection organization | 1 |
| regulation of cellular component organization | 1 |
| kinase activity | 1 |
| positive regulation of phosphorylation | 1 |
| positive regulation of catalytic activity | 1 |
| regulation of kinase activity | 1 |
| organelle organization | 1 |
| plasma membrane bounded cell projection organization | 1 |
| embryonic heart tube development | 1 |
| left/right pattern formation | 1 |
| cellular component organization | 1 |
| protein binding | 1 |
| cytoskeletal protein binding | 1 |
| kinase binding | 1 |
| GTPase binding | 1 |
| binding | 1 |
| Golgi apparatus subcompartment | 1 |
| intracellular vesicle | 1 |
| microtubule organizing center | 1 |
| cilium | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| endomembrane system | 1 |
Protein interactions and networks
STRING
642 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CIMAP3 | GPRASP2 | Q96D09 | 805 |
| CIMAP3 | RSPH1 | Q8WYR4 | 565 |
| CIMAP3 | NEDD9 | Q14511 | 534 |
| CIMAP3 | SMO | Q99835 | 517 |
| CIMAP3 | DENND2D | Q9H6A0 | 517 |
| CIMAP3 | TXLNB | Q8N3L3 | 473 |
| CIMAP3 | DYNLT1 | P63172 | 463 |
| CIMAP3 | DRC4 | O95995 | 460 |
| CIMAP3 | ARMC3 | Q5W041 | 459 |
| CIMAP3 | KIF24 | Q5T7B8 | 452 |
| CIMAP3 | CDHR3 | Q6ZTQ4 | 448 |
| CIMAP3 | STPG3 | Q8N7X2 | 448 |
| CIMAP3 | TEKT1 | Q969V4 | 433 |
| CIMAP3 | FOXJ1 | Q92949 | 420 |
| CIMAP3 | CCP110 | O43303 | 420 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CIMAP3 | PSMG3 | psi-mi:“MI:0914”(association) | 0.530 |
| CIMAP3 | EPHA2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (23): RAP2A (Affinity Capture-MS), ANAPC1 (Affinity Capture-MS), DAAM1 (Affinity Capture-MS), YES1 (Affinity Capture-MS), GNAQ (Affinity Capture-MS), PSMG3 (Affinity Capture-MS), DUSP28 (Affinity Capture-MS), EPHA2 (Affinity Capture-MS), ANAPC5 (Affinity Capture-MS), CRNN (Affinity Capture-MS), ANAPC1 (Affinity Capture-MS), PSMG3 (Affinity Capture-MS), DUSP28 (Affinity Capture-MS), CSNK1G1 (Affinity Capture-MS), GNAQ (Affinity Capture-MS)
ESM2 similar proteins: A1A5R9, A2AVQ5, A2RRW4, A2RSX4, A5WUY6, A9JS51, B0BM24, B0S4Q5, B1H283, D4A039, F1MMV1, Q08BC4, Q0VB26, Q2T9Q3, Q2TA11, Q2TBS4, Q3KQ80, Q3SX64, Q3TZ65, Q3ZCV2, Q4KKZ1, Q4KLY8, Q4R5Y0, Q5PQN4, Q5RAF2, Q5XI56, Q6ZN84, Q810P2, Q8BUG5, Q8C008, Q8C8J0, Q8IXM7, Q8N412, Q8N6G2, Q8N7U6, Q8N801, Q8TCI5, Q8WW14, Q9D067, Q9D131
Diamond homologs: Q2TBS4, Q8TCI5, Q9D9W1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
31 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
704 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:111347658:A:AG | acceptor_gain | 1.0000 |
| 1:111350101:TCTA:T | acceptor_loss | 1.0000 |
| 1:111350102:CTA:C | acceptor_loss | 1.0000 |
| 1:111350103:TAGCC:T | acceptor_loss | 1.0000 |
| 1:111350104:A:AG | acceptor_gain | 1.0000 |
| 1:111350104:AG:A | acceptor_loss | 1.0000 |
| 1:111350105:G:A | acceptor_loss | 1.0000 |
| 1:111350105:G:GA | acceptor_gain | 1.0000 |
| 1:111350105:GC:G | acceptor_gain | 1.0000 |
| 1:111350105:GCC:G | acceptor_gain | 1.0000 |
| 1:111350105:GCCC:G | acceptor_gain | 1.0000 |
| 1:111350105:GCCCT:G | acceptor_gain | 1.0000 |
| 1:111350189:TTCC:T | donor_gain | 1.0000 |
| 1:111347637:T:TA | acceptor_gain | 0.9900 |
| 1:111350098:A:AG | acceptor_gain | 0.9900 |
| 1:111350099:T:G | acceptor_gain | 0.9900 |
| 1:111350219:C:G | donor_gain | 0.9900 |
| 1:111346670:AG:A | donor_loss | 0.9800 |
| 1:111346671:GG:G | donor_loss | 0.9800 |
| 1:111346672:G:GC | donor_loss | 0.9800 |
| 1:111346673:T:G | donor_loss | 0.9800 |
| 1:111346951:A:T | donor_gain | 0.9800 |
| 1:111347047:GAT:G | donor_gain | 0.9800 |
| 1:111347662:T:G | acceptor_gain | 0.9800 |
| 1:111348507:T:TA | acceptor_gain | 0.9800 |
| 1:111348511:AACAG:A | acceptor_loss | 0.9800 |
| 1:111348512:ACAGG:A | acceptor_loss | 0.9800 |
| 1:111348513:CAGGA:C | acceptor_loss | 0.9800 |
| 1:111348514:A:AC | acceptor_loss | 0.9800 |
| 1:111348515:G:GC | acceptor_loss | 0.9800 |
AlphaMissense
1254 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:111347713:A:C | S67R | 0.991 |
| 1:111347715:T:A | S67R | 0.991 |
| 1:111347715:T:G | S67R | 0.991 |
| 1:111350164:T:C | F150L | 0.989 |
| 1:111350166:T:A | F150L | 0.989 |
| 1:111350166:T:G | F150L | 0.989 |
| 1:111351290:G:C | R180P | 0.989 |
| 1:111351296:G:C | R182P | 0.980 |
| 1:111350152:T:A | W146R | 0.979 |
| 1:111350152:T:C | W146R | 0.979 |
| 1:111347742:A:C | R76S | 0.974 |
| 1:111347742:A:T | R76S | 0.974 |
| 1:111347722:G:A | G70R | 0.973 |
| 1:111347722:G:C | G70R | 0.973 |
| 1:111348591:T:C | F112L | 0.970 |
| 1:111348593:T:A | F112L | 0.970 |
| 1:111348593:T:G | F112L | 0.970 |
| 1:111347754:G:C | R80S | 0.968 |
| 1:111347754:G:T | R80S | 0.968 |
| 1:111350154:G:C | W146C | 0.961 |
| 1:111350154:G:T | W146C | 0.961 |
| 1:111351301:G:C | A184P | 0.960 |
| 1:111350181:G:C | W155C | 0.959 |
| 1:111350181:G:T | W155C | 0.959 |
| 1:111347723:G:A | G70E | 0.958 |
| 1:111351304:T:G | Y185D | 0.958 |
| 1:111351308:T:C | L186P | 0.955 |
| 1:111350179:T:A | W155R | 0.953 |
| 1:111350179:T:C | W155R | 0.953 |
| 1:111347746:G:C | A78P | 0.950 |
dbSNP variants (sampled 300 via entrez): RS1000160193 (1:111331516 T>G), RS1000194599 (1:111331894 G>T), RS1000197153 (1:111329624 G>A), RS1000274730 (1:111350803 G>A), RS1000556042 (1:111333051 A>T), RS1000595753 (1:111340137 A>G), RS1000751132 (1:111346290 T>C), RS1000881634 (1:111352546 T>C), RS1000924660 (1:111339929 G>T), RS1001170983 (1:111349111 G>A), RS1001205474 (1:111349414 C>T), RS1001355254 (1:111352851 G>A), RS1001566901 (1:111328485 G>A), RS1001635892 (1:111328586 C>A,G), RS1001999010 (1:111338990 A>C,G,T)
Disease associations
OMIM: gene MIM:614234 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002666_6 | Interferon alpha levels in systemic lupus erythematosus | 3.000000e-06 |
| GCST003815_8 | Late-onset Alzheimer’s disease | 1.000000e-06 |
| GCST007059_13 | Response to antidepressants (symptom improvement) | 2.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006517 | interferon alpha measurement |
| EFO:1001870 | late-onset Alzheimers disease |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression, decreases methylation | 8 |
| mercuric bromide | increases expression, affects cotreatment | 2 |
| entinostat | increases expression, affects cotreatment | 2 |
| belinostat | increases expression, affects cotreatment | 2 |
| Benzo(a)pyrene | decreases methylation, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 2 |
| bisphenol A | increases expression | 1 |
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | increases expression, affects cotreatment | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | increases expression, affects cotreatment | 1 |
| Panobinostat | affects cotreatment, increases expression | 1 |
| Air Pollutants | increases expression, increases abundance | 1 |
| Amiodarone | increases expression | 1 |
| Diethylhexyl Phthalate | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Smoke | increases expression, increases abundance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.